- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 20, 2017
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Managed Care® (AJMC®) was cited in a Penn State News article that focused on the opioid epidemic on Wednesday. The study, “State Prescription Drug Monitoring Programs and Fatal Drug Overdoses,” examined the impact of prescription drug monitoring programs (PDMPs) on drug overdose deaths. Results of the study showed that PDMPs were not associated with the reductions in overall drug overdose mortality rate and may be related to increased mortality from illicit drugs and other, unspecified drugs.
The Thursday e-newsletter from National Pharmaceutical Council included 2 articles by AJMC® covering sessions at the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus meeting. The articles covered the growth of outcomes-based risk-sharing contracts and the benefits of these agreements, and the new guidance from FDA regarding healthcare economic information prior to a drug’s approval. For more coverage from AMCP Nexus, which was held October 16-19 in Dallas, Texas, visit the dedicated conference page.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
